UCLA joins collaboration to advance cancer immunotherapy research
UCLA joins collaboration to advance cancer immunotherapy research
Already a national leader in cancer immunotherapy, UCLA has joined forces with five of the nation’s other top cancer centers to form the Parker Institute for Cancer Immunotherapy. The consortium’s aim is to maximize the potential of cancer immunotherapy research.
Watch JCCC researcher Dr. Antoni Ribas and Sean Parker discuss the alliance and how they are harnessing the immune system to turn cancer into a curable disease. http://goo.gl/jBoflp
Immunotherapy News from China
- UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
- …Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to…
- UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
- …in Combination With Anti-PD-L1 Cancer Immunotherapy and …
- …Dosed in First-in-Human Clinical Study of Immunotherapy …
- JITC tumor and cancer immunotherapy papers collection
- Welcome to the submission|Journal for ImmunoTherapy of Cancer
- Immunotherapy shows promise for advanced lymphoma: study
- …from the Monotherapy Arm at the Phacilitate Immunotherapy …
- Allergy Immunotherapy Market to exceed US$ 3.33 Bn by 2025 …
Leave a Reply
You must be logged in to post a comment.